PROTEOMIC CHANGES IN MUSCLE CELLS WITH PULMONARY HYPERTENSION

$4,616P41FY2011RRNIH

Boston University Medical Campus, Boston MA

Investigators

Linked publications, trials & patents

Paper 31572832 Paper 31250273 Paper 29358899 Paper 27838321 Paper 27601046 Paper 26959868 Paper 26940164 Paper 26729453 Paper 26728195 Paper 26644780 Paper 26612686 Paper 26176386 Paper 26059764 Paper 26002792 Paper 25871794 Paper 25705143 Paper 25422678 Paper 25161153 Paper 24832382 Paper 24687996 Paper 24482490 Paper 24459079 Paper 24370893 Paper 24300896 Paper 24279456 Paper 24224699 Paper 24187947 Paper 24099043 Paper 24095926 Paper 24080071 Paper 24010836 Paper 24010834 Paper 24003177 Paper 23754800 Paper 23568027 Paper 23538872 Paper 23480678 Paper 23386333 Paper 23378518 Paper 23373960 Paper 23246965 Paper 23234263 Paper 23049804 Paper 23044924 Paper 23020394 Paper 23015739 Paper 22975326 Paper 22881449 Paper 22873817 Paper 22865881 Paper 22825743 Paper 22746280 Paper 22607061 Paper 22578329 Paper 22523474 Paper 22360375 Paper 22350411 Paper 22225232 Paper 22091710 Paper 21965658 Paper 21953041 Paper 21923145 Paper 21860601 Paper 21736361 Paper 21719793 Paper 21639522 Paper 21607198 Paper 21557257 Paper 21472584 Paper 21472566 Paper 21471211 Paper 21347431 Paper 21242968 Paper 21098023 Paper 21081667 Paper 20953780 Paper 20870723 Paper 20852023 Paper 20808847 Paper 20443730 Paper 20392170 Paper 20385555 Paper 20373761 Paper 20363743 Paper 20345121 Paper 20230064 Paper 20171118 Paper 20074541 Paper 20038609 Paper 20000724 Paper 19924777 Paper 19882131 Paper 19882118 Paper 19873993 Paper 19839595 Paper 19605355 Paper 19572074 Paper 19498000 Paper 19468063 Patent 7253159

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Pulmonary arterial hypertension (PAH) is a devastating disease with a usually fatal outcome There is as yet no reliable treatment for PAH, largely because the biochemical cause and course remain unknown.There are no adequate animal models. We are undertaking proteomics investigations of tissues from affected individuals, in order to gain knowledge about the pathways that are affected in conjunction with the disease.

View original record on NIH RePORTER →